Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2L6 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACSS2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NLGN4Y - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
FBXO7 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HS3ST1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
STAT1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Profile neighbors
ETV7 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
VIMP - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LYN - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PGM2L1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RAD18 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
EPSTI1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MIR6751 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
IFIT5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PSMB9 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CYB561 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TAP2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ITM2A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PARP9 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on